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Abstract
The objective of this study was to examine the differences in oscillatory brain dynamics in Alzheimer’s disease (AD) according to age
at onset using quantitative electroencephalography (EEG). We examined resting state electroencephalograms of 320 probable AD patients
and 246 controls, both categorized into a young ( 65 years) and old ( 65 years) group. Relative power in 4 different frequency bands
was calculated. The effect of age on global and regional relative power was examined. Globally, young AD patients showed lower alpha-
and higher delta-power than old AD patients. Regional analysis showed that these differences were most pronounced in the parieto-occipital
region. Young AD patients had lower beta- and higher theta-power than old patients in all but the temporal regions. In controls, there was
no age effect on global relative power in any frequency band. Young AD patients present with more severe slowing of spontaneous
oscillatory activity than old AD patients, which is most pronounced in the posterior brain areas. This finding supports the hypothesis that
early onset AD presents with a distinct endophenotype.
© 2012 Elsevier Inc.
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Large-scale neuronal activity can be measured with
electroencephalography (EEG). The hallmark oscillatory
brain dynamics finding in Alzheimer’s disease (AD) pa-
tients is a diffuse slowing of activity (Jeong, 2004), with
a decrease in alpha power and an increase in delta power
(Babiloni et al., 2004; Bennys et al., 2001; Moretti et al.,
2004). In addition, a reduced reactivity of alpha power on
eye opening has been reported in mild AD patients
(Babiloni et al., 2010). However, within the spectrum of
AD there is a large variation in severity of EEG abnor-
malities. In a former study in our memory clinic cohort,
visually rated EEG in AD patients varied from a com-
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Open access under the Elsevier OA license.pletely normal EEG to a combination of both focal and
diffuse abnormalities (Liedorp et al., 2009).
There is a growing body of evidence suggesting that
age at onset is related to manifestation of the disease.
Differences between young and old patients may point at
different underlying disease pathways. Understanding
these different pathways may provide new targets for
treatment. Young patients have a clinical profile with
more focal disturbances like aphasia and apraxia, in con-
trast to old patients where memory impairment is most
pronounced (Greicius et al., 2002; Koedam et al., 2010;
Licht et al., 2007; Seltzer and Sherwin, 1983; van der
Vlies et al., 2009). In addition, young patients often show
a different pattern of atrophy, with posterior regions
being more affected (Frisoni et al., 2007; Karas et al.,
2007). In a recent study, we assessed the influence of age
at onset on EEG abnormalities. Severity of EEG abnor-
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that young AD patients had more frequent and severe
EEG abnormalities than old AD patients (de Waal et al.,
2011). In this study we did not quantify the abnormali-
ties, nor could we say anything about regional distribu-
tion. Using quantitative EEG, a higher power in the theta
band and a more “abnormal” EEG with a younger age at
onset has been reported, but only in small samples or
using only a few electrode positions (Pucci et al., 1999;
Schreiter-Gasser et al., 1994).
In the present study we used quantitative EEG to com-
pare severity and location of oscillatory brain dynamics
changes in a large sample of young and old AD patients and
controls in order to gain more insight in the heterogeneity of
pathophysiological differences within Alzheimer’s disease.
We hypothesize that young AD patients will have a differ-
ent regional vulnerability than old AD patients, with more
severe slowing in the posterior brain regions.
2. Methods
2.1. Subjects
We included 320 AD patients and 246 controls. All
patients had been referred to the memory clinic of the
Alzheimer center of the VU University Medical Center,
Amsterdam, the Netherlands between September 2003 and
June 2009. Standardized dementia screening included a
history and, when available, an informant-based history, a
standard neurological examination, a cognitive examination
including Mini Mental State Examination (MMSE), EEG,
magnetic resonance imaging (MRI) of the brain, neuropsy-
chological evaluation, and laboratory tests. Patients were
diagnosed with probable AD according to the National
Institute of Neurological and Communicative Disorders and
Stroke and the Alzheimer’s Disease and Related Disorders
Association (NINCDS-ADRDA) criteria during a multidis-
ciplinary consensus meeting (McKhann et al., 1984). The
control group consisted of patients who presented at our
memory clinic with subjective complaints, but who had
normal clinical investigations and did not have significant
cognitive deficits (i.e., mild cognitive impairment [MCI]
criteria were not fulfilled) or major psychiatric disorder.
Both groups were categorized in young (65 years or young-
er; AD, n  113; controls, n  174) and old (older than 65
ears; AD, n  207; controls, n  72). The ethical review
oard of the VU University Medical Center has approved
he study. All patients gave written informed consent to use
heir clinical data for research purposes.
.2. EEG recording
All EEGs were recorded using the OSG digital equip-
ent (Brainlab; OSG b.v., Rumst, Belgium) from 21 elec-
rodes at the positions of the 10–20 system: Fp2, Fp1, F8,
7, F4, F3, A2, A1, T4, T3, C4, C3, T6, T5, P4, P3, O2, O1,
z, Cz, Pz, with an average reference which included all vlectrodes, except Fp2, Fp1, A2, and A1. Sample frequency
as 500 Hz. Electrode impedance was below 5 k. Initial
lter settings were time constant 1 second; low pass filter,
0 Hz. Patients were seated in a slightly reclined chair in a
ound attenuated room. Patients sat mainly with eyes
losed, EEG technicians were alert on keeping patients
wake by sound stimuli.
Four 10-second epochs of artifact free data (containing
o eye blinks, slow eye movements, excess muscle ac-
ivity, electrocardiogram [ECG] artifacts, etc.) were se-
ected from each EEG (HdW). Relative power of all
requency bands (delta 0.5– 4 Hz, theta 4 – 8 Hz, alpha
–13 Hz, beta 13–30 Hz, and gamma 30 – 48 Hz) was
alculated for all EEG channels using Fast Fourier Trans-
ormation. A flat window was applied over the full 4096
amples of each epoch. The power in the frequency bands
f interest was determined by averaging over the 4 ep-
chs (with Brain wave software, version 0.8.60, devel-
ped by C.J.S.; further information: home.kpn.nl/
tam7883/brainwave.html). By averaging the relative
ower of all electrodes a mean relative power for each
requency band was obtained. Our group used this
ethod in previous studies. Gamma band was not in-
luded in further analyses, because of the possible ad-
ixture of muscle artifacts in this frequency band
Whitham et al., 2007, 2008). Channels were clustered
nto 4 regions of interest: frontal, temporal, central, and
arieto-occipital. The frontal cluster was formed by chan-
els Fp1, Fp2, F7, F8, F3, F4, and Fz; the temporal
luster was formed by channels A1, A2, T3, T4, T5, and
6; the central cluster was formed by channels C4, C3,
nd Cz; and the parieto-occipital cluster was formed by
hannels P3, P4, Pz, O1, and O2. For further statistical
nalysis the mean relative power values were log trans-
ormed (x  log [x/1x]) to obtain a more Gaussian
istribution (Gasser et al., 1982).
.3. Statistics
PASW Statistics 18.0 for Mac (IBM Corp, Armonk,
Y, USA) was used for statistical analyses. Differences
etween groups for baseline characteristics were investi-
ated with t-tests and 2-tests where appropriate. First,
he effect of age (young vs. old) on relative power was
ested in both AD patients and controls, for each fre-
uency band separately, using 2-way analysis of variance
ANOVA). The mean relative power was used as depen-
ent variable, age (young vs. old), and diagnosis were
ntered in the model as binary fixed factors, sex was
ntered as covariate. Secondly, the effect of age on rel-
tive power in different brain regions was examined,
sing ANOVA for repeated measures. Age was used as
etween-subjects factor and brain area (4 regions: frontal,
emporal, central, and parieto-occipital) was used as
ithin-subjects factor. Relative power was the dependent
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separately for AD patients and controls.
3. Results
Baseline characteristics are summarized in Table 1. The
oung AD group was on average a few years older than the
oung control group (p  0.05) and the old AD group was
also a few years older than the old controls (p  0.05). The
young and old AD patients had comparable gender distri-
bution, MMSE, and disease duration. In the young and old
AD group a comparably small percentage of patients used
acetylcholinesterase inhibitors.
We used 2-way ANOVA to assess the effect of age on
the global power spectrum in AD patients and controls.
Global relative power values for AD and controls stratified
by age are given in Table 1. There was a main effect of
diagnosis in all frequency bands (alpha: F(1,561)  64.03;
p  0.001; beta: F(1,561)  36.07; p  0.001; theta:
(1,561)  162.72; p  0.001; delta: F(1,561)  14.61;
p  0.001), as AD patients had a higher delta and theta and
lower alpha and beta power than controls. In the alpha and
delta band we found a main effect of age (alpha: F(1,561)
12.16; p  0.001; delta: F(1,561)  15.40; p  0.001) and
an interaction between age and diagnosis (alpha:
F(1,561)  4.25; p  0.040; delta: F(1,561)  3.60;
 0.58). Young AD patients had a lower global alpha
ower and higher delta power than old AD patients, whereas
n controls there were no differences between the young and
ld. In the beta and theta band no age effects or interactions
ere found. When we repeated the analyses after exclusion
f acetylcholinesterase inhibitor users, the results did not
hange essentially, except for the interaction between age
nd diagnosis in the alpha band, which lost significance.






Age, years 59 (5) a
ex, female 62 (55%)
isease duration, years 3.8 (1.9)
sing AChEI 9 (8%)
MSE 20 (5)
lpha band, relative powerc,d,e 0.224 (0.12)
Beta band, relative powerc 0.157 (0.07)
Theta band, relative powerc 0.228 (0.09)
Delta band, relative powerc,d 0.333 (0.13)
Data are mean ( SD) or n (%). For EEG, raw data are shown, but statis
Key: AD, Alzheimer’s disease; AChEI, acetylcholinesterase inhibitor; EE
a Early onset AD group vs. young controls: p  0.05.
b Late onset AD group vs. old controls: p  0.05.
c Main effect of diagnosis: p  0.05.
d Main effect of age group: p  0.05.
e Interaction between age group and diagnosis: p  0.05.ge in AD patients and controls separately using ANOVA aor repeated measures (Fig. 1, Table 2). For AD patients
here was a main effect of age (F(1,317)  19.59;
 0.001) and area (F(2.78,881.30)  3.83; p  0.012)
nd an interaction between age and area (F(2.78,881.30) 
.83; p  0.012) in the alpha band. We found a lower
relative power in young AD patients as compared with old
patients in all brain regions, but the difference between
young and old patients was largest in the parieto-occipital
region. In the beta band, there was no main effect of age, but
there was a main effect of area (F(2.82,893.83)  30.76;
p  0.001) and an interaction between age and area
(F(2.82,893.83)  3.58; p  0.016). Young AD patients
ad a lower relative power than old patients in the frontal,
entral, and parieto-occipital region, while old patients had
ower relative power in the temporal regions. In the theta
and, there was no main effect of age, but there was a main
ffect of area (F(2.83,897.25)  6.26; p  0.001) and an
nteraction between age and area (F(2.83,897.25)  6.92;
 0.001), which mirrored the pattern observed in the beta
band. Young AD patients had a higher relative theta power
in the in the frontal, central, and parieto-occipital regions,
but old patients had a higher relative power in the temporal
regions. In the delta band, there were main effects of age
(F(1,317) 19.392; p 0.001) and area (F(2.87,910.48)
35.38; p  0.001) and an interaction between age and area
F(2.87,910.48)  4.43; p  0.005). Young AD patients
ad a higher relative delta power than old AD patients,
hich was most pronounced in the frontal and parieto-
ccipital regions. When we repeated the analyses after ex-
lusion of acetylcholinesterase inhibitor users, the results
id not change essentially.
For controls, there was a main effect of area
alpha: F(2.66,645.63)  26.35; p  0.001; delta:




75 (5) b 55 (7) 72 (4)
94 (45%) 77 (44%) 34 (47%)
3.4 (2.3) NA NA
10 (5%) NA NA
21 (5) 28 (2) 29 (1)
0.284 (0.13) 0.345 (0.16) 0.360 (0.14)
0.165 (0.09) 0.202 (0.08) 0.194 (0.07)
0.226 (0.12) 0.125 (0.06) 0.136 (0.07)
0.274 (0.12) 0.276 (0.11) 0.257 (0.10)
alyses were performed on log-transformed data.
troencephalogram; MMSE, Mini Mental State Examination.tical an
G, elecge nor an interaction between age and area in the alpha and
b1008.e28 H. de Waal et al. / Neurobiology of Aging 33 (2012) 1008.e25–1008.e31Fig. 1. Differences in relative power between young and old. Colors reflect the amount of difference in relative power between young and old. Blue means
less power in young than in old, red means more power in young than in old. (A) Differences in relative power between early onset and late onset Alzheimer’s
disease (AD) in 4 different brain regions. Interaction between area and age was significant (p 0.05) in all frequency bands. (B) Differences in relative power






















































1008.e29H. de Waal et al. / Neurobiology of Aging 33 (2012) 1008.e25–1008.e31delta band. In the beta band there was no main effect of age,
but there was a main effect of area (F(2.89,701.97) 34.79;
 0.001) and an interaction between age and area
F(2.89,701.97)  11.41; p  0.001). Old controls had
ower beta power in the temporal and parieto-occipital re-
ions than young controls, while such an effect was not
bserved in other brain regions. In the theta band there was
o main effect of age, but there was a main effect of area
F(2.94,714.42)  9.33; p  0.001) and an interaction
etween age and area (F(2.94,714.42)  8.93; p  0.001).
ld controls had higher theta power than young controls in
ll regions, except for the central region, where there was no
ifference between groups.
. Discussion
The main finding of this study is that young AD patients
ad relatively less power in the faster alpha band and more
ower in the slower delta band than old AD patients and that
his difference was greatest in the posterior regions. More-
ver, in the beta band and theta band we also found a
ifferent regional distribution between young and old AD
atients. In controls, there was no difference in global rel-
tive power between age groups. We did find some specific
egional differences between young and old controls in the
eta and theta band, but these were smaller than the differ-
nces in AD.
Previous EEG studies have shown a decrease of power in
he fast frequency bands and increase of power in slower
requency bands in AD patients compared with controls
Table 2
























Shown are mean relative power values, mean ( SD), for all frequency ban
while statistical analyses were performed on log-transformed data.Babiloni et al., 2004; Bennys et al., 2001; Jeong, 2004; yoretti et al., 2004). We confirm these former findings as
he entire group of AD patients had more delta and theta
ower and less alpha and beta power than controls. Vari-
bility in severity of EEG abnormalities in AD has been
hown before. In a study including 35 AD patients and 35
ontrols, quantitative EEG discriminated between patients
nd controls, but within the group of AD patients there was
large, unexplained, variation in the ratios between fast and
low activity (Bennys et al., 2001). In a former study on
EG in a memory clinic population, we found that AD
atients more often show EEG abnormalities than nonde-
ented individuals. Within the group of AD patients how-
ver, EEGs ranged from completely normal to both focal
nd diffuse abnormalities (Liedorp et al., 2009). As yet, it
emains unclear what causes this heterogeneity. Severity of
he disease and the use of acetylcholinesterase inhibitors
ave been found to influence these differences (Gianotti et
l., 2008; Rodriguez et al., 2002; van der Hiele et al., 2007),
ut this does not explain the entire picture.
In the current study, we focused on age at onset as a
eterminant of severity and distribution of oscillatory brain
ynamics. Our findings are in line with the few previous
tudies on quantitative EEG analysis in young and old AD
atients (Duffy et al., 1984; Matousek et al., 2001; Miyau-
hi et al., 1994; Pucci et al., 1999; Schreiter-Gasser et al.,
994). In a study using visual classification of power spec-
ra, a more abnormal EEG was correlated with a younger
ge of onset, but regional differences were not taken into
ccount (Pucci et al., 1999). In a very small cohort of 9
band Theta band Delta band
(0.07) 0.213 (0.09) 0.399 (0.14)
(0.07) 0.234 (0.10) 0.309 (0.12)
(0.11) 0.232 (0.10) 0.271 (0.12)
(0.08) 0.240 (0.11) 0.305 (0.15)
(0.08) 0.213 (0.11) 0.335 (0.13)
(0.08) 0.243 (0.12) 0.263 (0.11)
(0.12) 0.223 (0.12) 0.224 (0.11)
(0.10) 0.229 (0.13) 0.235 (0.13)
(0.08) 0.117 (0.05) 0.357 (0.13)
(0.08) 0.138 (0.07) 0.258 (0.09)
(0.11) 0.137 (0.07) 0.224 (0.11)
(0.10) 0.112 (0.06) 0.214 (0.12)
(0.07) 0.126 (0.07) 0.326 (0.13)
(0.07) 0.158 (0.09) 0.245 (0.09)
(0.10) 0.137 (0.07) 0.212 (0.11)
(0.09) 0.124 (0.07) 0.200 (0.11)



























1008.e30 H. de Waal et al. / Neurobiology of Aging 33 (2012) 1008.e25–1008.e31trols, maximal group differences between young AD pa-
tients and controls were found in the right posterior tempo-
ral lobe, whereas maximal group differences between old
AD patients and their controls were found in the midfrontal
and bilateral anterior areas (Duffy et al., 1984). A direct
comparison between early onset and late onset AD was not
made however.
We found more slowing (relatively less alpha and more
delta power) in young than in old AD patients. Moreover,
we observed a different regional distribution of EEG abnor-
malities, with relatively more disturbed activity in the pa-
rieto-occipital regions in young AD, while in old AD pa-
tients activity was relatively more disturbed in the temporal
regions. A study using source localization has provided
evidence that EEG findings are a marker of underlying brain
pathology (Prichep, 2007). Furthermore, these findings co-
incide with results from studies in other modalities and
suggest a different regional vulnerability in young onset
patients. AD is typically characterized by memory impair-
ment accompanied by atrophy of the medial temporal lobe.
In patients with early onset however, the cognitive profile is
often dominated by nonmemory problems such as apraxia,
aphasia, and visuospatial dysfunction, and atrophy is often
observed in parietal and posterior brain regions (Frisoni et
al., 2005; Ishii et al., 2005; Karas et al., 2007; Koedam et
al., 2010; Shiino et al., 2006; Snowden et al., 2007; Surib-
hatla et al., 2004). Furthermore, in early onset AD reduced
metabolism has been found in the parietal and posterior
association cortices (Kemp et al., 2003; Kim et al., 2005;
McMurtray et al., 2008; Nitrini et al., 2000; Rabinovici et
al., 2010; Sakamoto et al., 2002).
Strengths of the present study are the large population of
consecutive patients and controls, who all received an EEG
as part of the standard work-up. We measured relative
power, a well-known measure of quantitative EEG analysis,
which allowed us to study regional changes in oscillatory
brain activity in a reliable and detailed way. Possible limi-
tations are the fact that we used persons with subjective
complaints as control group, as these patients are known to
have an increased risk of progression to dementia. The main
question in this study involved a comparison between early
and late onset AD however, which is not influenced by the
control group.
In this study we focused on regional differences in os-
cillatory activity between early and late onset AD. Regional
analyses do not take into account connections between neu-
rons. AD has been termed a disconnection syndrome, with
evidence for disrupted functional and structural connectivity
in AD patients (Delbeuck et al., 2003; He et al., 2009).
Future studies should focus on functional networks, as it can
be hypothesized that these networks are differentially com-
promised in early onset and late onset AD.
In conclusion, we found that young AD patients present
with more severe slowing of spontaneous oscillatory activ-
ity than old AD patients, which is most pronounced in theposterior brain areas. This finding supports the hypothesis
that early onset AD presents with a distinct endophenotype.
A picture emerges that there may be different pathways
leading to AD in young and old patients. These pathways
may in turn be linked to differences in prognosis and re-
sponse to therapy. Furthermore, the biological underpin-
nings of differences between old and young patients may
lead to new targets for therapy.
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